Australia markets close in 5 hours 27 minutes

Herborium Group, Inc. (HBRM)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 02:14PM EDT

Herborium Group, Inc.

One Bridge Plaza North
Suite 275
Fort Lee, NJ 07024
United States

IndustryDrug Manufacturers - Specialty & Generic
Full-time employees2

Key executives

NameTitlePayExercisedYear born
Dr. Agnes P. OlszewskiFounder, Chairman, CEO, President, CFO & Principal Accounting Officer150kN/A1957
Dr. James P. Gilligan MSIB, Ph.D.Co-Founder, Scientific Advisor & Director66.67kN/A1952
Mr. Daniel TeoSenior Vice President of Business DevelopmentN/AN/AN/A
Mr. Lawrence WooAsia Business Advisor & DirectorN/AN/AN/A
Mr. Roger JonesUK & EU Advisor and DirectorN/AN/A1943
Mr. John E. DonahueController & SEC AdvisorN/AN/A1950
Amounts are as of 31 December 2007, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. It offers dermatology products, which include AcnEase, herbal medicinal product for enhancing conditions associated with hormonal acne and multiple symptoms of Rosacea; and AcnEase Skin Management System for the treatment of acne marks/scars. The company also provides sexual health and performance products that are non-prescriptive alternatives to selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, and surgical procedures, including hysterectomy. In addition, it offers energy restoration products, such as Lasting Energy, a herbal supplement to decrease the symptoms associated with hangovers and eliminating jet-lag; and for treating overall depletion of energy due to competitive sports, high levels of stress, and extensive sexual activities, as well as other long term or temporary physical demands. Further, the company provides Liver Activator Series for the treatment of liver damage; ProstAid, a natural product focuses on Benign Prostate Hyperplasia; and CardioVitae, a fermentation based product using a Lucidium derived cell line targeting cardio-pulmonary insufficiencies. Herborium Group, Inc. sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. The company was founded in 2000 and is headquartered in Fort Lee, New Jersey.

Corporate governance

Herborium Group, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.